Trimel Pharmaceuticals Corporation

Trimel Pharmaceuticals Corporation

May 02, 2014 15:37 ET

Trimel to Report First Quarter 2014 Results and Host Conference Call to Update Investors

TORONTO, ONTARIO--(Marketwired - May 2, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) will report its first quarter financial results for the period ended March 31, 2014 on Thursday, May 8th 2014 after market close.

Management of the Company will host a conference call to discuss these results and update investors on the status of its business on Friday, May 9th 2014, at 8:30 a.m. Eastern Daylight Time. Following the discussion, Trimel executives will address inquiries from investment analysts.

To access the call live, please dial 416-340-2216 or 1-866-223-7781. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays.

A replay of the conference call will be available until 7:00 p.m. Eastern Daylight Time on Friday, May 16th, 2014 by dialing 905-694-9451 or 1-800-408-3053, using access code: 6382379#.

About Trimel

Trimel is a specialty pharmaceutical company actively developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders. An NDA for CompleoTRT™, a product utilizing Trimel's licensed bioadhesive intranasal gel technology, has been accepted for review by the FDA for regulatory approval in the United States. For more information, please visit

Contact Information